老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Immunovant, Inc.

15.15
+0.31002.09%
盤後：15.150.00000.00%16:51 EDT
成交量：103.97萬
成交額：1,569.90萬
市值：25.73億
市盈率：-5.79
高：15.25
開：14.75
低：14.73
收：14.84
資料載入中...
總覽公司新聞公告
2020/08/21

重要事件披露

8-K - Current report
2020/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/29

重要事件披露

8-K - Current report
2020/06/15

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/14

重要事件披露

8-K - Current report
2020/04/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/10

招股説明書

General form for registration of securities under the Securities Act of 1933
2020/04/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/04/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/08

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2020/04/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/30

重要事件披露

8-K - Current report
2020/02/28

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多